Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
3D Printed Ph-Responsive Tablets Containing N-Acetylglucosamine-Loaded Methylcellulose Hydrogel for Colon Drug Delivery Applications Publisher Pubmed



Asadi M1, 4 ; Salehi Z1 ; Akrami M2 ; Hosseinpour M3 ; Jockenhovel S4, 5 ; Ghazanfari S4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biochemical and Pharmaceutical Engineering, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran
  2. 2. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Research and Development Department, Naya Life Sciences d.o.o, Netherlands
  4. 4. Aachen-Maastricht Institute for Biobased Materials, Faculty of Science and Engineering, Maastricht University, Netherlands
  5. 5. Department of Biohybrid & Medical Textiles (BioTex), AME-Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Forckenbeckstrabe 55, Aachen, 52072, Germany

Source: International Journal of Pharmaceutics Published:2023


Abstract

The pH-responsive drug release approach in combination with three-dimensional (3D) printing for colon-specific oral drug administration can address the limitations of current treatments such as orally administered solid tablets. Such existing treatments fail to effectively deliver the right drug dosage to the colon. In order to achieve targeted drug release profiles, this work aimed at designing and producing 3D printed tablet shells using Eudragit® FS100 and polylactic acid (PLA) where the core was filled with 100 µl of N-acetylglucosamine (GlcNAc)-loaded methyl cellulose (MC) hydrogel. To meet the requirements of such tablets, the effects of polymer blending ratios and MC concentrations on physical, thermal, and material properties of various components of the tablets and most importantly in vitro drug release kinetics were investigated. The tablets with 80/20 wt% of Eudragit® FS100/PLA and the drug-loaded hydrogel with 30 mg/ml GlcNAc and 3% w/v MC showed the most promising results having the best printability, processability, and drug release kinetics besides being non-cytotoxic. Manufacturing of these tablets will be the first milestone in shifting from the conventional “one size fits all” approach to personalized medicine where different dosages and various combinations of drugs can be effectively delivered to the inflammation site. © 2023 The Authors